BlackRock to buy majority stake in Humana’s CenterWell clinics for $2.8 billion
Humana says the transaction will fund clinic operations and possible expansion, subject to approvals.
TL;DR
- Humana said BlackRock will acquire Welsh Carson’s majority stake in CenterWell in a transaction valued at $2.8 billion.
- The clinic network includes 150 Medicare Advantage-focused primary-care sites, and Humana says proceeds will support operations and expansion.
- The deal is expected to close in the fourth quarter of 2026, subject to customary and regulatory approvals; Humana said it does not expect a material effect on its 2026 adjusted earnings guidance.
Humana announced that BlackRock would acquire Welsh Carson’s majority ownership in CenterWell, valuing the transaction at about $2.8 billion. The company described the network as operating 150 primary-care clinics focused on Medicare Advantage members. [1]
Humana said proceeds over the next two years would help fund existing clinic operations, additional clinics and strategic acquisitions. STAT reported the transaction and placed it in the context of the private-equity firm’s exit after investing in the venture since 2020. [2]
The company’s filing says the transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions and state and federal regulatory approval. The filing also says the deal is not expected to materially affect Humana’s 2026 adjusted earnings guidance. [1]
The ownership transfer has not yet closed, and the final conditions remain subject to review. The announcement does not specify how the investment will alter clinic operations, patient access or future acquisitions beyond the stated funding purpose. [2]
Why it matters
The transaction would shift ownership of a sizeable primary-care network and may influence how capital is allocated to Medicare-focused clinics, subject to approvals and later operating choices.
Editor's note
Transaction terms are company-reported; closing remains subject to regulatory approvals.